Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2020-08-07 Director's Dealing
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. It details specific share transactions (disposals) made by an executive (Kim Jung-Ho) of the company Oscotec. This type of filing is a standard regulatory disclosure for insider trading/shareholding changes by company directors, which corresponds to the 'Director's Dealing' category.
2020-08-07 Korean
투자판단관련주요경영사항(유한양행의 얀센바이오테크 기술이전 마일스톤 분배)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details a specific financial event: the receipt of a milestone payment from a technology transfer agreement between Yuhan Corporation and Janssen Biotech. Since this is a specific corporate disclosure regarding a financial event (milestone payment) that does not fit into categories like dividends, share issues, or earnings releases, it is best classified as a general regulatory filing.
2020-06-05 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company Oscotec, covering the period from January 1, 2020, to March 31, 2020. It contains detailed financial information, business descriptions, capital structure, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-14 Korean
감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Oscotec' (주식회사 오스코텍) for the fiscal year ending December 31, 2019. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a formal, full-length financial audit document, not an announcement or a summary, and therefore fits the 'Audit Report' category. FY 2019
2020-03-30 Korean
연결감사보고서 (2019.12)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Oscotec, covering the fiscal years 2018 and 2019. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows), and detailed notes to the financial statements. As it contains comprehensive financial statements for a specific period (not a full 10-K annual report, but an interim/annual audit package), it fits the definition of an Interim/Quarterly Report (IR) or, in this specific context of a standalone audit report, it is classified as an Interim/Quarterly Report (IR) due to the presence of substantive financial data. FY 2019
2020-03-30 Korean
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2019, covering company overview, history, capital changes, shareholder information, and detailed business descriptions. It contains financial data and management analysis, which is characteristic of an Annual Report (10-K equivalent in the Korean market). FY 2019
2020-03-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.